BIOMAT Database Logo BIOMAT Database Logo

Successful renal transplantation in patients positive for hepatitis B antigen. 1974

S N Chatterjee, and J E Payne, and A G Redeker, and T V Berne

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008297 Male Males
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001789 Blood Group Antigens Sets of cell surface antigens located on BLOOD CELLS. They are usually membrane GLYCOPROTEINS or GLYCOLIPIDS that are antigenically distinguished by their carbohydrate moieties. Blood Group,Blood Group Antigen,Blood Groups,Antigen, Blood Group,Antigens, Blood Group,Group Antigen, Blood,Group, Blood,Groups, Blood
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S N Chatterjee, and J E Payne, and A G Redeker, and T V Berne
Renal transplantation in hepatitis B surface antigen-positive patients.
June 1993, Transplantation proceedings,
S N Chatterjee, and J E Payne, and A G Redeker, and T V Berne
Renal transplantation in hepatitis B surface antigen-positive patients.
February 1987, Transplantation proceedings,
S N Chatterjee, and J E Payne, and A G Redeker, and T V Berne
Renal transplantation is not contraindicated in hepatitis B surface antigen positive patients.
August 1992, Transplantation proceedings,
S N Chatterjee, and J E Payne, and A G Redeker, and T V Berne
Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment.
June 2004, Transplantation proceedings,
S N Chatterjee, and J E Payne, and A G Redeker, and T V Berne
Allogeneic marrow transplantation in patients positive for hepatitis B surface antigen.
January 1991, Blood,
S N Chatterjee, and J E Payne, and A G Redeker, and T V Berne
Renal transplantation in hepatitis B surface antigen-positive patients: single-center experience in Korea.
August 1994, Transplantation proceedings,
S N Chatterjee, and J E Payne, and A G Redeker, and T V Berne
Renal transplantation in patients positive for hepatitis B or C (con).
August 1998, Transplantation proceedings,
S N Chatterjee, and J E Payne, and A G Redeker, and T V Berne
Renal transplantation in patients positive for hepatitis B or C (pro).
August 1998, Transplantation proceedings,
S N Chatterjee, and J E Payne, and A G Redeker, and T V Berne
Hepatitis B reactivation in patients positive for hepatitis B surface antigen undergoing autologous hematopoietic cell transplantation.
August 2003, Leukemia & lymphoma,
S N Chatterjee, and J E Payne, and A G Redeker, and T V Berne
Outcome of renal transplantation in hepatitis B surface antigen-positive patients after introduction of lamivudine.
November 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!